Reply to Cottin et al., to Johannson et al., to Scholand and Wells, and to Crowley et al

Affiliations

¹ Department of Medicine and.
² Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.
³ Division of Pulmonary Medicine, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
⁴ Division of Pulmonary and Critical Care, Department of Medicine, Mount Auburn Hospital/Beth Israel Lahey Health, Harvard Medical School, Boston, Massachusetts.
⁵ Department of Thoracic Imaging, University of Lille, Lille, France; and.
⁶ Division of Allergy, Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.

Comment

Ganesh Raghu et al. Am J Respir Crit Care Med. 2023.

. 2023 Jun 1;207(11):1542-1543.

doi: 10.1164/rccm.202305-0786LE.

¹ Department of Medicine and.
² Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.
³ Division of Pulmonary Medicine, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
⁴ Division of Pulmonary and Critical Care, Department of Medicine, Mount Auburn Hospital/Beth Israel Lahey Health, Harvard Medical School, Boston, Massachusetts.
⁵ Department of Thoracic Imaging, University of Lille, Lille, France; and.
⁶ Division of Allergy, Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.

No abstract available

Comment on

Progressive Pulmonary Fibrosis: Should the Timelines Be Taken Out of the Definition?
Cottin V, Brown KK, Flaherty KR, Wells AU. Cottin V, et al. Am J Respir Crit Care Med. 2022 Nov 15;206(10):1293-1294. doi: 10.1164/rccm.202206-1143LE. Am J Respir Crit Care Med. 2022. PMID: 35868029 Free PMC article. No abstract available.
Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults.
Scholand MB, Wells AU. Scholand MB, et al. Am J Respir Crit Care Med. 2022 Nov 15;206(10):1296. doi: 10.1164/rccm.202207-1260LE. Am J Respir Crit Care Med. 2022. PMID: 35868030 Free PMC article. No abstract available.
Progressive Pulmonary Fibrosis: Putting the Cart Before the Horse.
Johannson KA, Kolb M, Fisher JH, Walsh SLF. Johannson KA, et al. Am J Respir Crit Care Med. 2022 Nov 15;206(10):1294-1295. doi: 10.1164/rccm.202206-1166LE. Am J Respir Crit Care Med. 2022. PMID: 35868031 Free PMC article. No abstract available.
Anti-acid Therapies in Idiopathic Pulmonary Fibrosis: Premature to Dismiss?
Crowley LE, Wilson A, Thickett DR. Crowley LE, et al. Am J Respir Crit Care Med. 2022 Nov 15;206(10):1297. doi: 10.1164/rccm.202207-1420LE. Am J Respir Crit Care Med. 2022. PMID: 35921176 Free PMC article. No abstract available.

1. Cottin V, Brown KK, Flaherty KR, Wells AU. Progressive pulmonary fibrosis: should the timelines be taken out of the definition? Am J Respir Crit Care Med . 2022;206:1293–1294. - PMC - PubMed
1. Johannson KA, Kolb M, Fisher JH, Walsh SLF. Progressive pulmonary fibrosis: putting the cart before the horse. Am J Respir Crit Care Med . 2022;206:1294–1295. - PMC - PubMed
1. Scholand MB, Wells AU. Comment on idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults. Am J Respir Crit Care Med . 2022;206:1296. - PMC - PubMed
1. Crowley LE, Wilson A, Thickett DR. Anti-acid therapies in idiopathic pulmonary fibrosis: premature to dismiss? Am J Respir Crit Care Med . 2022;206:1297. - PMC - PubMed
1. Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med . 2022;205:e18–e47. - PMC - PubMed